Join the SmallCapReview mailing list.

AUPH Aurinia Pharmaceuticals: A late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need.  More.
MYGN Myriad Genetics: A  personalized medicine company, that focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. MYGN has a collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx. More.     
ICPT Intercept Pharmaceuticals: A biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat orphan and more prevalent liver diseases utilizing its expertise in bile acid chemistry.  OCA has received orphan drug designation in both the United States and Europe for the treatment of PBC. More.                 
Commentary

Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints, Achieving Highest Complete Remission Rate of Any Global Lupus


Small Cap Biotechs Gain Steam As Cutting Regulations Are On The Table


Small Cap Defense


5 Small Cap Biotechs For March


3 Small Cap Stocks For Years of High Returns


Markets
Volume Leaders
Advancers/Decliners
52 Week Highs/Lows
Small-Cap Index
Tools
Check Futures Here
Quotes
Level II Quotes
Stock Screener
Performance by Industry
Pre-Market
After Hours Market
World Markets
Education

 

Visit Our Resources Page

Past Articles Worth Reading

 

 

 

 


 

 

 

 

 

 

 

 Where Small Cap Stocks Thrive Since 1999                                           

7 Small Caps With Big Dividends


5 Beaten Down Value Stocks...

10 Small Cap Stocks That Could Double In The Next Three Months...

Where Small Caps Are Working...

Define Small Cap Stock... Market Cap between $250 million and $1 billion.

Aurinia Closes US$173.1 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common...(AUPH)

Myriad Genetics Announces Five Scientific Presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting...(MYGN)

Why Now Is A Good Time To Own Small Cap Banks...

Rate Hike Creates New Opportunity In Small Caps...

Small Cap Tick Pilot Program Disappointing... We seen this coming from a mile away.

Meaning Of The Fifth Letter Of Nasdaq Ticker Symbols...

Cup With Handle Chart Pattern...

Where Small Caps Are Less Risky...

Aurinia Announces Acceptance of Voclosporin Late-Breaking Presentation at the National Kidney Foundation 2017 Spring Clinical Meetings...(AUPH)

Best Small Caps By Share Price Growth...


Aurinia Pharmaceuticals (AUPH)

 

Website: www.Auriniapharma.com

"Voclosporin has the potential to become a best in class medication and the first approved treatment for LN in the U.S. and Europe."

More on AUPH here...


Myriad Genetics (MYGN)

Website: www.Myriad.com

"Myriad has the deepest diagnostic pipeline across the disease spectrum."

More on MYGN here...


Intercept Pharmaceuticals (ICPT)

 

"A Biopharmaceutical Company Focused On The Development And Commercialization Of Novel Therapeutics To Treat Chronic Liver Diseases."

More on ICPT here...


Follow Us On

Twitter


10 High Yield Small Cap Dividend Stocks For 2017


MYGN's BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's...(MYGN)


The Next Leg Of The Small Cap Rally Starts Now


The Long And Short Of Small Cap Options


Microcap Stocks - There's A Lot To Like About Them


Compelling Reasons To Keep Small Caps


4 Small Caps To Look At


Small Cap Stocks And Emerging Markets Ripe For Growth


How To Play The Small Cap Comeback


Small Cap Stocks Are Poised For Big Gains


The State Of Microcaps - A Look Back At 2016 And Into The Future


Bank Rally Likely To Shift To Microcap Banks


Why Do Alpha Seekers Find It In Small Caps?


MYGN's Prolaris® Test Significantly Improves the Risk Classification for One Third of Men Diagnosed with Localized Prostate Cancer...(MYGN)


MYGN Joins Small Cap 600


A Most Wonderful Year For Small Caps


Why Small Caps Remain Some Of The Top Stocks To Invest In


Small Cap Stocks - Time For Active Investing


5 Small Cap Picks


5 Charts: Small Caps With A Bull Flag


Small Cap ETFs For A New Era


Trump, Rolling Stones


Year End Review: Small Cap Stocks



Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks via email. You can sign-up here.


 

"A Primer In Small Cap Investing"

SmallCapReview.com® is a leading destination for small-cap picks and news. The Purpose of SmallCapReview.com is to profile and bring awareness to companies with a market cap of less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap stocks to watch via various newswires. We will strive to bring you the undiscovered, the undervalued, and the oversold. SmallCapReview.com does not give "buy" recommendations, price targets nor suggest entry and exit points.

"A Look at Small Cap Stocks that may no longer be Small Caps"


 

 

 


B
© 1999-2017 SmallCapReview.com. Any questions or comments regarding this site should be directed to editor@smallcapreview.com